Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

In NAC Docket, NAD+ Drug Firm Suggests US FDA Get Serious About Dietary Ingredient Regulations

Dec 07 2021

• By Malcolm Spicer

• Source: Alamy

Related Content

AHPA Offers Hard Copy Supporting NAC's Use In Dietary Supplements Pre-DSHEA

Oct 13 2021

Split Decision In Breach-of-Contract Battle Of Litigation War Between ChromaDex, Elysium

Oct 06 2021

NAC’s Longevity In US Dietary Supplement Market Swings On Comments As NDI Notifications

Nov 30 2021

Attention Shoppers And Investors: ChromaDex Makes Tru Niagen Available At Walmart

Jun 07 2021

US FDA Put On The Clock About NAC's Use As Dietary Ingredient After Amazon Ends Sales

Jun 02 2021

Widely Available Unapproved Hangover Remedies Concern US FDA As Encouraging Overindulgence

Jul 30 2020

Drug Innovation Needs Exclusivity For Some Natural Substances, PhRMA Recommends

Jul 25 2019

Additional Topics

International United States US States Dietary Supplements FDA Ingredients Advertising, Marketing & Sales Business Strategies Commercial Companies Clinical Trials Compliance Consumer Drug Approval Standards Enforcement Manufacturing Policy Regulation Research & Development Safety

More from Regulation

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window